Market Cap 8.58B
Revenue (ttm) 12.67B
Net Income (ttm) 390.00M
EPS (ttm) N/A
PE Ratio 14.87
Forward PE 14.59
Profit Margin 3.08%
Debt to Equity Ratio 0.54
Volume 1,119,700
Avg Vol 1,482,012
Day's Range N/A - N/A
Shares Out 117.73M
Stochastic %K 46%
Beta 0.89
Analysts Sell
Price Target $77.00

Company Profile

Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners, and alternate sites of care worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The company offers dental merchandise, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, and PP...

Industry: Medical Distribution
Sector: Healthcare
Phone: 631 843 5500
Address:
135 Duryea Road, Melville, United States
BillionerOfKing
BillionerOfKing Dec. 4 at 6:43 PM
$HSIC Current Stock Price: $73.26 Contracts to trade: $75 HSIC Dec 19 2025 Call Entry: $0.81 Exit: $1.14 ROI: 40% Hold ~28 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
JackDarwin
JackDarwin Dec. 4 at 1:35 PM
$HSIC Bullish Harami Candlestick Pattern Formed
0 · Reply
ZacksResearch
ZacksResearch Dec. 2 at 1:46 PM
$HSIC expands partnership with vVARDIS — what it means for the stock! 🦷 📈 Exclusive U.S. distribution rights for Curodont starting 2026 🤝 Boosts Dental business, which may support a rebound in stock movement 📊 Market cap of $8.78B, with 2025 EPS expected to grow 3.6% over 2024 See how this impacts HSIC’s future moves 👉 https://www.zacks.com/stock/news/2798126/hsic-stock-benefits-from-expanded-partnership-with-vvardis?cid=sm-stocktwits-2-2798126-body-22969&ADID=SYND_STOCKTWITS_TWEET_2_2798126_BODY_22969
0 · Reply
ZacksResearch
ZacksResearch Dec. 2 at 12:46 PM
$HSIC just scored a major catalyst — are traders paying attention yet? Henry Schein grabbed exclusive U.S. rights to Curodont, expanding its vVARDIS partnership, and the move is boosting expectations for a rebound in its Dental business. Full breakdown here 👉 https://www.zacks.com/stock/news/2798126/hsic-stock-benefits-from-expanded-partnership-with-vvardis?cid=sm-stocktwits-2-2798126-teaser-22968&ADID=SYND_STOCKTWITS_TWEET_2_2798126_TEASER_22968
0 · Reply
ZacksResearch
ZacksResearch Dec. 1 at 2:21 PM
AI revolution in dentistry: Why $HSIC could rebound! 📈🦷 Henry Schein One's new AI workflows and AWS partnership promise to modernize dental practices, significantly enhancing operational efficiency and patient care. 🚀 Despite a recent 1.2% dip post-announcement, this news could support a rebound in stock movement. Opportunity assessment here 👉 https://www.zacks.com/stock/news/2797526/hsic-stock-set-to-benefit-from-henry-schein-ones-workflow-launch?cid=sm-stocktwits-2-2797526-body-22865&ADID=SYND_STOCKTWITS_TWEET_2_2797526_BODY_22865
0 · Reply
ZacksResearch
ZacksResearch Dec. 1 at 11:53 AM
$HSIC about to catch a tailwind? 🚀 HSIC is set to benefit from Henry Schein One’s new workflow launch — a fresh catalyst that could tighten execution and boost investor sentiment. See what this launch means for the stock 👉 https://www.zacks.com/stock/news/2797526/hsic-stock-set-to-benefit-from-henry-schein-ones-workflow-launch?cid=sm-stocktwits-2-2797526-teaser-22811&ADID=SYND_STOCKTWITS_TWEET_2_2797526_TEASER_22811
0 · Reply
SPYmyQQQ
SPYmyQQQ Nov. 25 at 3:42 PM
🎯 Target Hit 🏁 📨 From Nov 13, 2025 🏛️ $HSIC 💵 Entry: $73.3500 ✅ Exit: $75.1911 💰 P/L: +2.51% 👉 FREE TRIAL! spymyqqq/join/
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 17 at 12:47 AM
0 · Reply
SPYmyQQQ
SPYmyQQQ Nov. 13 at 9:02 PM
🚀 New Signal ✅ 🏛️ $HSIC 🗓️ Nov 13, 2025 💵 Entry: $73.35 🎯 Target (Opt.): $75.19 (+2.51%) 👉 FREE TRIAL! spymyqqq/join/
0 · Reply
ZZZZniiiiight
ZZZZniiiiight Nov. 11 at 1:40 PM
$OMI I work in medical sales and this company is a dying one that’s for sure. Better to invest it $CAH or Medline once they IPO. $BX owns a major stake in it. Also $MCK and $HSIC would be better investments.
2 · Reply
Latest News on HSIC
Henry Schein Expands Partnership with vVARDIS

Dec 1, 2025, 4:34 PM EST - 3 days ago

Henry Schein Expands Partnership with vVARDIS


Artisan Select Equity Fund Q3 2025 Portfolio Review

Nov 27, 2025, 5:04 AM EST - 8 days ago

Artisan Select Equity Fund Q3 2025 Portfolio Review

ARMK ELV GOOG LRCX


Henry Schein, Inc. (HSIC) Q3 2025 Earnings Call Transcript

Nov 4, 2025, 11:56 AM EST - 4 weeks ago

Henry Schein, Inc. (HSIC) Q3 2025 Earnings Call Transcript


Henry Schein Announces $750 Million Share Repurchase Plan

Sep 9, 2025, 5:10 PM EDT - 3 months ago

Henry Schein Announces $750 Million Share Repurchase Plan


Henry Schein Medical Expands SolutionsHub with Colaborate

Sep 9, 2025, 10:18 AM EDT - 3 months ago

Henry Schein Medical Expands SolutionsHub with Colaborate


Henry Schein: The Case For An Upgrade From Hold To Buy

Aug 14, 2025, 1:50 PM EDT - 4 months ago

Henry Schein: The Case For An Upgrade From Hold To Buy


Henry Schein (HSIC) Q2 EPS Drops 11%

Aug 5, 2025, 12:31 PM EDT - 4 months ago

Henry Schein (HSIC) Q2 EPS Drops 11%


Henry Schein, Inc. (HSIC) Q2 2025 Earnings Call Transcript

Aug 5, 2025, 10:39 AM EDT - 4 months ago

Henry Schein, Inc. (HSIC) Q2 2025 Earnings Call Transcript


Henry Schein falls after missing quarterly profit estimates

Aug 5, 2025, 7:40 AM EDT - 4 months ago

Henry Schein falls after missing quarterly profit estimates


Henry Schein Reports Second Quarter 2025 Financial Results

Aug 5, 2025, 6:00 AM EDT - 4 months ago

Henry Schein Reports Second Quarter 2025 Financial Results


Henry Schein: Still Bullish Even As Shares Languish

Jul 31, 2025, 1:24 PM EDT - 4 months ago

Henry Schein: Still Bullish Even As Shares Languish


IntelePeer Joins Henry Schein One Academic Partner Program

Jul 17, 2025, 9:16 AM EDT - 5 months ago

IntelePeer Joins Henry Schein One Academic Partner Program


Henry Schein Post Earnings Review

May 17, 2025, 9:30 AM EDT - 7 months ago

Henry Schein Post Earnings Review


Henry Schein, Inc. (HSIC) Q1 2025 Earnings Call Transcript

May 5, 2025, 4:26 PM EDT - 7 months ago

Henry Schein, Inc. (HSIC) Q1 2025 Earnings Call Transcript


Henry Schein Reports First Quarter 2025 Financial Results

May 5, 2025, 6:00 AM EDT - 7 months ago

Henry Schein Reports First Quarter 2025 Financial Results


BillionerOfKing
BillionerOfKing Dec. 4 at 6:43 PM
$HSIC Current Stock Price: $73.26 Contracts to trade: $75 HSIC Dec 19 2025 Call Entry: $0.81 Exit: $1.14 ROI: 40% Hold ~28 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
JackDarwin
JackDarwin Dec. 4 at 1:35 PM
$HSIC Bullish Harami Candlestick Pattern Formed
0 · Reply
ZacksResearch
ZacksResearch Dec. 2 at 1:46 PM
$HSIC expands partnership with vVARDIS — what it means for the stock! 🦷 📈 Exclusive U.S. distribution rights for Curodont starting 2026 🤝 Boosts Dental business, which may support a rebound in stock movement 📊 Market cap of $8.78B, with 2025 EPS expected to grow 3.6% over 2024 See how this impacts HSIC’s future moves 👉 https://www.zacks.com/stock/news/2798126/hsic-stock-benefits-from-expanded-partnership-with-vvardis?cid=sm-stocktwits-2-2798126-body-22969&ADID=SYND_STOCKTWITS_TWEET_2_2798126_BODY_22969
0 · Reply
ZacksResearch
ZacksResearch Dec. 2 at 12:46 PM
$HSIC just scored a major catalyst — are traders paying attention yet? Henry Schein grabbed exclusive U.S. rights to Curodont, expanding its vVARDIS partnership, and the move is boosting expectations for a rebound in its Dental business. Full breakdown here 👉 https://www.zacks.com/stock/news/2798126/hsic-stock-benefits-from-expanded-partnership-with-vvardis?cid=sm-stocktwits-2-2798126-teaser-22968&ADID=SYND_STOCKTWITS_TWEET_2_2798126_TEASER_22968
0 · Reply
ZacksResearch
ZacksResearch Dec. 1 at 2:21 PM
AI revolution in dentistry: Why $HSIC could rebound! 📈🦷 Henry Schein One's new AI workflows and AWS partnership promise to modernize dental practices, significantly enhancing operational efficiency and patient care. 🚀 Despite a recent 1.2% dip post-announcement, this news could support a rebound in stock movement. Opportunity assessment here 👉 https://www.zacks.com/stock/news/2797526/hsic-stock-set-to-benefit-from-henry-schein-ones-workflow-launch?cid=sm-stocktwits-2-2797526-body-22865&ADID=SYND_STOCKTWITS_TWEET_2_2797526_BODY_22865
0 · Reply
ZacksResearch
ZacksResearch Dec. 1 at 11:53 AM
$HSIC about to catch a tailwind? 🚀 HSIC is set to benefit from Henry Schein One’s new workflow launch — a fresh catalyst that could tighten execution and boost investor sentiment. See what this launch means for the stock 👉 https://www.zacks.com/stock/news/2797526/hsic-stock-set-to-benefit-from-henry-schein-ones-workflow-launch?cid=sm-stocktwits-2-2797526-teaser-22811&ADID=SYND_STOCKTWITS_TWEET_2_2797526_TEASER_22811
0 · Reply
SPYmyQQQ
SPYmyQQQ Nov. 25 at 3:42 PM
🎯 Target Hit 🏁 📨 From Nov 13, 2025 🏛️ $HSIC 💵 Entry: $73.3500 ✅ Exit: $75.1911 💰 P/L: +2.51% 👉 FREE TRIAL! spymyqqq/join/
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 17 at 12:47 AM
0 · Reply
SPYmyQQQ
SPYmyQQQ Nov. 13 at 9:02 PM
🚀 New Signal ✅ 🏛️ $HSIC 🗓️ Nov 13, 2025 💵 Entry: $73.35 🎯 Target (Opt.): $75.19 (+2.51%) 👉 FREE TRIAL! spymyqqq/join/
0 · Reply
ZZZZniiiiight
ZZZZniiiiight Nov. 11 at 1:40 PM
$OMI I work in medical sales and this company is a dying one that’s for sure. Better to invest it $CAH or Medline once they IPO. $BX owns a major stake in it. Also $MCK and $HSIC would be better investments.
2 · Reply
MisterSplashyPants
MisterSplashyPants Nov. 7 at 12:59 AM
$CMG $HSIC $BA $BE $TYL Jim Cramer’s take on these 5 stocks…
1 · Reply
IN0V8
IN0V8 Nov. 6 at 5:22 AM
$HSIC Leerink Partners raises target price to $75 from $70 Piper Sandler raises target price to $83 from $77 Wells Fargo raises target price to $76 from $70
0 · Reply
JarvisFlow
JarvisFlow Nov. 5 at 7:35 PM
JP Morgan has adjusted their stance on Henry Schein ( $HSIC ), setting the rating to Overweight with a target price of 76 → 78.
0 · Reply
JarvisFlow
JarvisFlow Nov. 5 at 6:46 PM
Barrington Research has updated their rating for Henry Schein ( $HSIC ) to Outperform with a price target of 79.
0 · Reply
JarvisFlow
JarvisFlow Nov. 5 at 6:09 PM
Morgan Stanley has adjusted their stance on Henry Schein ( $HSIC ), setting the rating to Underweight with a target price of 55 → 58.
0 · Reply
JarvisFlow
JarvisFlow Nov. 5 at 3:13 PM
Wells Fargo has adjusted their stance on Henry Schein ( $HSIC ), setting the rating to Equal-Weight with a target price of 70 → 76.
0 · Reply
JarvisFlow
JarvisFlow Nov. 5 at 2:12 PM
Evercore ISI Group has updated their rating for Henry Schein ( $HSIC ) to Outperform with a price target of 90.
0 · Reply
AStrokeOfLuck
AStrokeOfLuck Nov. 4 at 2:57 PM
0 · Reply
OptionRunners
OptionRunners Nov. 4 at 1:59 PM
$HSIC +10% on earnings
0 · Reply
ZacksResearch
ZacksResearch Nov. 4 at 1:58 PM
$HSIC beats earnings and raises 2025 guidance! 🚀 Adjusted EPS up 13.1% YoY, surpassing the Zacks Consensus Estimate by 8.7%. Sales growth driven by strong performance across segments, with notable growth in Global Distribution and Value-Added Services 📈. Discover full insights and what’s next for HSIC 👉 https://www.zacks.com/stock/news/2784385/hsic-stock-jumps-on-q3-earnings-and-revenue-beat-25-outlook-up?cid=sm-stocktwits-2-2784385-body-19244&ADID=SYND_STOCKTWITS_TWEET_2_2784385_BODY_19244
0 · Reply
OpenOutcrier
OpenOutcrier Nov. 4 at 1:26 PM
$HSIC (+8.0% pre) HSIC Stock Jumps on Q3 Earnings and Revenue Beat, '25 Outlook Up https://ooc.bz/l/83000
0 · Reply
ZacksResearch
ZacksResearch Nov. 4 at 12:58 PM
$HSIC pops after a strong Q3 beat 🚀 Earnings and revenue topped estimates, and management lifted its 2025 outlook — clear signs of solid business momentum ahead. See the full earnings recap here 👉 https://www.zacks.com/stock/news/2784385/hsic-stock-jumps-on-q3-earnings-and-revenue-beat-25-outlook-up?cid=sm-stocktwits-2-2784385-teaser-19243&ADID=SYND_STOCKTWITS_TWEET_2_2784385_TEASER_19243
1 · Reply